Determination of everolimus in whole blood using the Abbott IMx® sirolimus microparticle enzyme immunoassay
Authors:
- J. Carlos TutorJTJ. Carlos Tutor
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 40 (1-2) , 132-136
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipientsClinical Biochemistry, 2006
- Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimusClinical Biochemistry, 2006
- The Role of Therapeutic Monitoring of Everolimus in Solid Organ TransplantationTherapeutic Drug Monitoring, 2005
- An evaluation of the Abbott IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet methodAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005
- Cross-reactivity Of The Major Everolimus Hydroxy Metabolites With The Innofluor?? Certican?? Immunoassay For Clinical Tdm Of EverolimusTherapeutic Drug Monitoring, 2005
- Comparison of the Seradyn Innofluor?? Certican?? Assay on TDXFLX?? System With LC/MS-MSTherapeutic Drug Monitoring, 2005
- Clinical Pharmacokinetics of EverolimusClinical Pharmacokinetics, 2004
- Clinical Pharmacokinetics of SirolimusClinical Pharmacokinetics, 2001
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Evaluation of method-comparison data.Clinical Chemistry, 1981